US › Healthcare

Simulations Plus Inc (SLP)

US · Healthcare · Health Information Services

$18.35+0.22%
Last close · 2026-08-04

Latest quarter · ended 2026-05-31

Revenue
$21.9M
Revenue YoY
+7.5%
Net profit
$3.6M
Profit YoY
+105.3%
EPS
$0.30
EPS estimate
$0.23
Net margin
16.3%

EPS came in at 0.30 against a street estimate of 0.23 — a beat of 30.4%.

Key statistics

Market cap
$368.7M
P/E
45.6
Forward P/E
52.9
P/B
2.65
Book value
$6.88
EPS (TTM)
$0.40
52-week high
$21.01
52-week low
$11.09
50-day MA
$17.49
200-day MA
$16.17
Beta
1.31

Analyst view

Analysts rate Simulations Plus Inc a strong buy (5 buy, 1 hold, 0 sell out of 6) with an average price target of $17.25.

Shareholding

Insiders
16.92%
Institutions
82.06%

Largest institutional holders

FundStake
First Light Asset Management, LLC13.02%
BlackRock Inc6.19%
Morgan Stanley - Brokerage Accounts4.39%
Arnhold & S. Bleichroeder Advisers, LLC3.67%
Vanguard Capital Management, LLC3.66%
Marshall Wace Asset Management Ltd3.13%
Rockefeller Capital Management L.P.2.91%
Tributary Capital Management, LLC2.66%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Simulations Plus Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.